-
Circle the dates on your calendar for Reproductive Health 2008, the annual meeting for the Association of Reproductive Health Professionals (ARHP), Planned Parenthood Federation of America, and the Society of Family Planning. The meeting is scheduled for Sept. 17-20 in Washington, DC.
-
Have you administered the initial dose of Gardasil, the quadrivalent human papillomavirus (HPV) vaccine, to a young woman with private insurance, only to later discover that her policy does not cover vaccine reimbursement?
-
-
What can you tell teens about preventing chlamydia? Check the following information from the Centers for Disease Control and Prevention (CDC):
-
When it comes to emergency contraception (EC), what does your clinic offer? A new review has found that mifepristone is the most effective EC method to prevent unwanted pregnancy; however, the drug has not gained U.S. regulatory approval for that use.
-
The woman in your exam room says she has severe headaches that usually begin about two days before her menstrual cycle. When they occur, they get more severe in intensity. She does not report any signs of neurological aura, such as flashing lights or tingling sensations, with the headaches. What's your diagnosis?
-
When it comes to administering the vaccine for human papillomavirus (HPV), providers are following the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices' recommendation to target all girls ages 11-12 for routine vaccination.
-
The Nurses' Health Study reported an update of its data on the use of hormone therapy and stroke, focusing on the timing of initiation of treatment and the effect of estrogen doses.
-
The authors hypothesized that certain pain symptoms characterize IC/PBS. They reviewed criteria used in two recent studies to look for commonalities.
-
It has been common practice to "strip" or "sweep" membranes after 38 weeks to initiate spontaneous labor or, at least, to discourage patients from delivering after 42 weeks.
